Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 525

1.

Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase.

Chan BC, Ip M, Lau CB, Lui SL, Jolivalt C, Ganem-Elbaz C, Litaudon M, Reiner NE, Gong H, See RH, Fung KP, Leung PC.

J Ethnopharmacol. 2011 Sep 1;137(1):767-73. doi: 10.1016/j.jep.2011.06.039. Epub 2011 Jul 1.

PMID:
21782012
2.

Synergistic effects of diosmetin with erythromycin against ABC transporter over-expressed methicillin-resistant Staphylococcus aureus (MRSA) RN4220/pUL5054 and inhibition of MRSA pyruvate kinase.

Chan BC, Ip M, Gong H, Lui SL, See RH, Jolivalt C, Fung KP, Leung PC, Reiner NE, Lau CB.

Phytomedicine. 2013 May 15;20(7):611-4. doi: 10.1016/j.phymed.2013.02.007. Epub 2013 Mar 27.

PMID:
23541215
4.

Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump.

Sabatini S, Gosetto F, Manfroni G, Tabarrini O, Kaatz GW, Patel D, Cecchetti V.

J Med Chem. 2011 Aug 25;54(16):5722-36. doi: 10.1021/jm200370y. Epub 2011 Aug 3.

PMID:
21751791
6.

Remarkable synergies between baicalein and tetracycline, and baicalein and beta-lactams against methicillin-resistant Staphylococcus aureus.

Fujita M, Shiota S, Kuroda T, Hatano T, Yoshida T, Mizushima T, Tsuchiya T.

Microbiol Immunol. 2005;49(4):391-6.

7.

Identification of pyruvate kinase in methicillin-resistant Staphylococcus aureus as a novel antimicrobial drug target.

Zoraghi R, See RH, Axerio-Cilies P, Kumar NS, Gong H, Moreau A, Hsing M, Kaur S, Swayze RD, Worrall L, Amandoron E, Lian T, Jackson L, Jiang J, Thorson L, Labriere C, Foster L, Brunham RC, McMaster WR, Finlay BB, Strynadka NC, Cherkasov A, Young RN, Reiner NE.

Antimicrob Agents Chemother. 2011 May;55(5):2042-53. doi: 10.1128/AAC.01250-10. Epub 2011 Feb 28.

8.

Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus.

Kalia NP, Mahajan P, Mehra R, Nargotra A, Sharma JP, Koul S, Khan IA.

J Antimicrob Chemother. 2012 Oct;67(10):2401-8. doi: 10.1093/jac/dks232. Epub 2012 Jul 17.

9.

Synergistic effects between silibinin and antibiotics on methicillin-resistant Staphylococcus aureus isolated from clinical specimens.

Kang HK, Kim HY, Cha JD.

Biotechnol J. 2011 Nov;6(11):1397-408. doi: 10.1002/biot.201000422. Epub 2011 Apr 13.

PMID:
21491604
10.

Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus.

Kumar A, Khan IA, Koul S, Koul JL, Taneja SC, Ali I, Ali F, Sharma S, Mirza ZM, Kumar M, Sangwan PL, Gupta P, Thota N, Qazi GN.

J Antimicrob Chemother. 2008 Jun;61(6):1270-6. doi: 10.1093/jac/dkn088. Epub 2008 Mar 10.

11.

Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus.

Mun SH, Joung DK, Kim YS, Kang OH, Kim SB, Seo YS, Kim YC, Lee DS, Shin DW, Kweon KT, Kwon DY.

Phytomedicine. 2013 Jun 15;20(8-9):714-8. doi: 10.1016/j.phymed.2013.02.006. Epub 2013 Mar 26.

PMID:
23537748
12.

From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump.

Sabatini S, Kaatz GW, Rossolini GM, Brandini D, Fravolini A.

J Med Chem. 2008 Jul 24;51(14):4321-30. doi: 10.1021/jm701623q. Epub 2008 Jun 25.

PMID:
18578473
14.

Synergistic effect of tetrandrine and ethidium bromide against methicillin-resistant Staphylococcus aureus (MRSA).

Lee YS, Han SH, Lee SH, Kim YG, Park CB, Kang OH, Keum JH, Kim SB, Mun SH, Shin DW, Kwon DY.

J Toxicol Sci. 2011 Oct;36(5):645-51.

15.

Artesunate has its enhancement on antibacterial activity of β-lactams via increasing the antibiotic accumulation within methicillin-resistant Staphylococcus aureus (MRSA).

Jiang W, Li B, Zheng X, Liu X, Pan X, Qing R, Cen Y, Zheng J, Zhou H.

J Antibiot (Tokyo). 2013 Jun;66(6):339-45. doi: 10.1038/ja.2013.22. Epub 2013 Apr 3.

PMID:
23549351
16.

[A study on the active efflux system in methicillin-resistant Staphylococcus aureus].

Gao XL, Liu B, Jin K, Cheng J, Li JB, Zhou SS.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009 Dec;21(12):722-5. Chinese.

17.

In vitro potentiation of ampicillin, oxacillin, norfloxacin, ciprofloxacin, and vancomycin by sanguinarine against methicillin-resistant Staphylococcus aureus.

Obiang-Obounou BW, Kang OH, Choi JG, Keum JH, Kim SB, Mun SH, Shin DW, Park CB, Kim YG, Han SH, Lee JH, Kwon DY.

Foodborne Pathog Dis. 2011 Aug;8(8):869-74. doi: 10.1089/fpd.2010.0759. Epub 2011 Apr 27.

PMID:
21524196
18.

Methicillin-resistant Staphylococcus aureus (MRSA) pyruvate kinase as a target for bis-indole alkaloids with antibacterial activities.

Zoraghi R, Worrall L, See RH, Strangman W, Popplewell WL, Gong H, Samaai T, Swayze RD, Kaur S, Vuckovic M, Finlay BB, Brunham RC, McMaster WR, Davies-Coleman MT, Strynadka NC, Andersen RJ, Reiner NE.

J Biol Chem. 2011 Dec 30;286(52):44716-25. doi: 10.1074/jbc.M111.289033. Epub 2011 Oct 26.

20.

Synergy between baicalein and penicillins against penicillinase-producing Staphylococcus aureus.

Qian M, Tang S, Wu C, Wang Y, He T, Chen T, Xiao X.

Int J Med Microbiol. 2015 Sep;305(6):501-4. doi: 10.1016/j.ijmm.2015.05.001. Epub 2015 May 16.

PMID:
26028441
Items per page

Supplemental Content

Write to the Help Desk